181 related articles for article (PubMed ID: 26958047)
1. Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.
Sun Y; Li D; Lv XH; Hua SC; Han JC; Xu F; Li XD
J Res Med Sci; 2015 Dec; 20(12):1138-46. PubMed ID: 26958047
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
3. [Protein and mRNA expression of osteopontin in lung cancer and clinical significance thereof].
Gui SY; Li HH; Zuo L; Zhou Q; Wu Q; Wang Y
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3219-23. PubMed ID: 18399118
[TBL] [Abstract][Full Text] [Related]
4. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
7. Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC).
Jin Y; Tong DY; Tang LY; Chen JN; Zhou J; Feng ZY; Shao CK
Chin J Cancer Res; 2012 Jun; 24(2):103-8. PubMed ID: 23359766
[TBL] [Abstract][Full Text] [Related]
8. [Correlation study between OPN, CD44v6, MMP-9 and distant metastasis in laryngeal squamous cell carcinoma].
Yang L; Shang X; Zhao X; Lin Y; Liu J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):989-92. PubMed ID: 23373240
[TBL] [Abstract][Full Text] [Related]
9. [Expressions and significances of CD147, OPN and MMP-2 in oral squamous cell carcinoma].
Zhang C; Man DP; Ma SM; Cao SW; Li DW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 43(5):683-6. PubMed ID: 23230738
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
Li L; Mei TH; Zhou XD; Zhang XG
Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
[TBL] [Abstract][Full Text] [Related]
12. [Expression of Ras-GTPase-activating protein SH 3 domain binding protein and osteopontin in esophageal squamous carcinoma and their effects on prognosis].
Liu JG; Zhang HZ; Wei YP; Wu C; Cao YK; Wang M
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jan; 10(1):73-6. PubMed ID: 17253181
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of RhoC and osteopontin in esophageal squamous carcinoma and association with the patients' prognosis].
Zhang HZ; Liu JG; Wei YP; Wu C; Cao YK; Wang M
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1612-5. PubMed ID: 17121713
[TBL] [Abstract][Full Text] [Related]
15. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.
Yan CH; Lv M; Li H; Song X; Yan F; Cao S; Ren X
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1371-8. PubMed ID: 25555465
[TBL] [Abstract][Full Text] [Related]
17. [Chemokine receptor 7 induces metastasis of NSCLC via upregulating MMP-9 expression].
Li Y; Liu W; Fang L; Nan J; Zhang Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1016-20. PubMed ID: 21081040
[TBL] [Abstract][Full Text] [Related]
18. [Effect of osteopontin on expression of matrix metalloproteinase 13 in human knee osteoarthritic chondrocytes].
Jiang W; Lei G; Lin B; Wang H; Lu M; Gao S; Zhang F; Zeng C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Nov; 28(11):1342-5. PubMed ID: 25639047
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer.
Jin Y; Tong DY; Chen JN; Feng ZY; Yang JY; Shao CK; Li JP
PLoS One; 2012; 7(10):e48575. PubMed ID: 23119061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
